Classifications of Charcot–Marie–Tooth disease refers to the types and subtypes of Charcot–Marie–Tooth disease (CMT), a genetically and clinically heterogeneous group of inherited disorders of the ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder that’s both progressive and incurable. But now, nerve specialists ...

Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT ... Nevertheless, despite the fact that finding a disease-causing ...

A recent study by Dr. Jordan Verplank, Assistant Professor in the Department of Anatomy, Physiology, and Genetics at the ...

Common clinical manifestations of CMTX, as in other forms of Charcot-Marie-Tooth disease (CMT), are distal muscle wasting and weakness, hyporeflexia, distal sensory disturbance, and foot deformities.

An east Auckland teenager with a rare genetic condition is grateful for having received equipment that will make it easier ...

French biotech Pharnext has seen the value of its shares collapse after it revealed that its lead drug, a treatment for Charcot-Marie-Tooth (CMT) disease, failed to make the grade in a phase 3 trial.

The plan of a case-control study that will investigate the potential role of the activation of immunologic pathways in patients with Charcot-Marie-Tooth disease (CMT) and chronic inflammatory ...

The postural balance and visual dependence seem to be different between patients with hereditary demyelinating neuropathies like Charcot-Marie-Tooth (CMT) and acquired demyelinating neuropathies ...

She will succeed Gerry DeRoche, who is retiring after 14 years in the role. Laura MacNeill has become CEO of the CMT Research Foundation, a nonprofit group that raises funding to develop treatments ...